All News

Navigating EHE: Connecting with Experts and Support

August 9th 2025, 6:00pm

Article

Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.

Immunoglobulin Replacement Not Associated With Fewer Infections in CLL

August 9th 2025, 2:00pm

Article

Among patients with chronic lymphocytic leukemia, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections.

New Clinical Trials Launch as Cancer Treatment Studies Advance

August 8th 2025, 9:00pm

Article

Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid tumor, and urothelial cancers.

Using Social Media to Amplify the Patient Voice and Advocacy

August 8th 2025, 8:00pm

Video

Clara Cirks is a stage 4 lung cancer patient who uses platforms like TikTok and Instagram to amplify her voice and raise awareness about patient advocacy

FDA Approves Hernexeos for Non-Squamous Non-Small Cell Lung Cancer

August 8th 2025, 5:49pm

Article

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

A Moment of Kindness I’ll Never Forget During Cancer Treatment

August 8th 2025, 5:00pm

Article

During World Cancer Support Month, I’m remembering a moment in 2012 a group of teachers — especially Mrs. Reed — lifted me up with unexpected kindness.

Incidence of Early-Onset Liver Cancer in Younger Patients Decreasing

August 8th 2025, 4:00pm

Article

The incidence of hepatocellular carcinoma has risen between 2010 and 2019; however, for people under 50 years of age, the proportion of cases has declined.

Epkinly Combo Reduces Risk of Progression or Death in Follicular Lymphoma

August 8th 2025, 3:00pm

Article

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

How Biomarkers May Help Guide Kidney Cancer Treatment Earlier

August 8th 2025, 1:00pm

Video

Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.

Please Don’t Call Me ‘Dear’: A Poem From Cancer Treatment

August 7th 2025, 9:00pm

Article

I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.